Effective January 2nd, 2015, Catamaran Corporation (NASDAQ: CTRX) has completed acquisition of Salveo Specialty Pharmacy for the reported purchase price of $260 million. Catamaran released a statement affirming the acquisition emphasizing the PBM’s ongoing commitment to expanding their specialty Rx side. It appears specialty pharmacy will continue to be the hot topic going into 2015.
Catamaran manages more than 350 million prescriptions each year for over 32 million members.
For the full article please click here: Catamaran Completes Acquisition of Salveo Specialty Pharmacy